175 related articles for article (PubMed ID: 19927011)
1. Reverse remodeling and improved function by antihypertensive treatment in hypertensive patients with coronary artery disease.
Yui Y; Kodama K; Hirayama A; Nishio R; Iwanaga Y; Nonogi H; Haze K; Sumiyoshi T; Yui N; Hosoda S; Kawai C;
J Hypertens; 2010 Jan; 28(1):178-85. PubMed ID: 19927011
[TBL] [Abstract][Full Text] [Related]
2. Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies.
Almazov VA; Shlyakhto EV; Konrady AO; Macsimova TA; Zaharov DV; Rudomanov OG
Med Sci Monit; 2000; 6(2):309-13. PubMed ID: 11208328
[TBL] [Abstract][Full Text] [Related]
3. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
[TBL] [Abstract][Full Text] [Related]
4. [Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats].
Xu R; Zhang Y; Zhang M; Li XC; Cai H; Chen WQ; Zhu H; Ge ZM; Zhang W
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3199-204. PubMed ID: 16405840
[TBL] [Abstract][Full Text] [Related]
5. The extent of regional wall motion abnormalities identifies patients at risk of extensive left ventricular remodeling: implications for the design of post myocardial infarction trials.
Zanolla L; Marino P; Golia G; Anselmi M; Zardini P; Borghi C; Ambrosioni E
G Ital Cardiol; 1999 Jan; 29(1):20-6. PubMed ID: 9987043
[TBL] [Abstract][Full Text] [Related]
6. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
Ferrari R;
Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606
[TBL] [Abstract][Full Text] [Related]
7. The effect of landiolol on hemodynamics and left ventricular function in patients with coronary artery disease.
Goto K; Shingu C; Miyamoto S; Miyakawa H; Noguchi T
J Clin Anesth; 2007 Nov; 19(7):523-9. PubMed ID: 18063207
[TBL] [Abstract][Full Text] [Related]
8. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
Dahlöf B; Devereux R; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Julius S; Kjeldsen S; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H
Am J Hypertens; 1997 Jul; 10(7 Pt 1):705-13. PubMed ID: 9234823
[TBL] [Abstract][Full Text] [Related]
9. [Beneficial effects of Hartil on cardiovascular remodeling process in elderly and old patients with isolated systolic arterial hypertension].
Kiphshidze N; Zubiashvili T; Chagunava K
Georgian Med News; 2008 Jan; (154):7-13. PubMed ID: 18323584
[TBL] [Abstract][Full Text] [Related]
10. Management of moderate to severe hypertension and proteinuria by nifedipine retard and perindopril after renal transplantation.
Grekas D; Dioudis C; Kalevrosoglou I; Papoulidou F; Goutsaridis N; Alivanis P; Tourkantonis A
Clin Nephrol; 1995 Nov; 44(5):299-302. PubMed ID: 8605709
[TBL] [Abstract][Full Text] [Related]
11. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
[TBL] [Abstract][Full Text] [Related]
12. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
13. Change in pulse pressure/stroke index in response to sustained blood pressure reduction and its impact on left ventricular mass and geometry changes: the life study.
Palmieri V; Bella JN; Gerdts E; Wachtell K; Papademetriou V; Nieminen MS; Dahlöf B; Devereux RB
Am J Hypertens; 2008 Jun; 21(6):701-7. PubMed ID: 18437127
[TBL] [Abstract][Full Text] [Related]
14. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
[TBL] [Abstract][Full Text] [Related]
15. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS).
JATOS Study Group
Hypertens Res; 2008 Dec; 31(12):2115-27. PubMed ID: 19139601
[TBL] [Abstract][Full Text] [Related]
16. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
18. [Effect of ACE-inhibitors on left ventricular remodeling after acute anterior or posterior myocardial infarct. Cine- magnetic resonance tomography study].
Konermann M; Odenthal HJ; Altmann C; Laschewski F; Rawert B; Trappe HJ; Sanner BM
Wien Med Wochenschr; 2000; 150(12):249-55. PubMed ID: 11008329
[TBL] [Abstract][Full Text] [Related]
19. [Effect of ambulatory supervised cardiac training on arterial hypertension in patients with coronary artery disease and arterial hypertension].
Kałka D; Sobieszczańska M; Marciniak W; Popielewicz-Kautz A; Markuszewski L; Chorebała A; Korzeniowska J; Janczak J; Adamus J
Pol Merkur Lekarski; 2007 Jan; 22(127):9-14. PubMed ID: 17477082
[TBL] [Abstract][Full Text] [Related]
20. Coronary artery disease and hypertension: outcomes of a pharmacist-managed blood pressure program.
McConnell KJ; Zadvorny EB; Hardy AM; Delate T; Rasmussen JR; Merenich JA;
Pharmacotherapy; 2006 Sep; 26(9):1333-41. PubMed ID: 16945056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
